J A P Spijkers-Hagelstein

Statistics

Publications

Citations

408

H-Index

Active since

2012

Affiliations

Erasmus MC - Sophia Children’s Hospital(Current)

Center for Translational Molecular Medicine

J A P Spijkers-Hagelstein is an author at Erasmus MC - Sophia Children’s Hospital specializing in molecular oncology, medicine, and glucocorticoid resistance.

Publications per year

2012–2016

Publications

Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants

Emma M. C. Driessen, Eddy H.J. Van Roon, J A P Spijkers-Hagelstein et al. · Haematologica · 2013 · 105 citations · Full text

Medicine, Genetics, Oncology +17

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia

Kirsten Canté-Barrett, J A P Spijkers-Hagelstein, Jessica G. C. A. M. Buijs-Gladdines et al. · Leukemia · 2016 · 91 citations · Full text

Medicine, Cancer Biology, Oncology +15

Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia

J A P Spijkers-Hagelstein, Pauline Schneider, Esther Hulleman et al. · Leukemia · 2012 · 69 citations

Life Sciences, Genetics, Molecular Genetics +12

Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia

J A P Spijkers-Hagelstein, Sandra S. Pinhanços, Pauline Schneider et al. · Leukemia · 2012 · 67 citations

Life Sciences, Cell Biology, Molecular Biology +12

Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL

J A P Spijkers-Hagelstein, Sandra S. Pinhanços, Pauline Schneider et al. · Leukemia · 2013 · 37 citations

Life Sciences, Genetics, Molecular Biology +7

1–5 of 7